VAERS data: 5,435 adverse events, 45 deaths in 6 days since new Covid booster

by WorldTribune Staff, October 31, 2022

Between Oct. 21 and 27 there were a total of 5,435 reports of adverse events, including 45 deaths and 280 serious injuries, from the new Covid bivalent booster shot, according to data from the CDC’s Vaccine Adverse Event Reporting System (VAERS).

Between Dec. 14, 2020 and Oct. 21, 2022, there have been 1,447,520 reports of adverse events following Covid jabs submitted to VAERS.

The data includes a total of 31,696 reports of deaths and 263,462 serious injuries during the same time period.

And yet, Team Biden continues to aggressively push Americans to get the booster shots.

“If you’re fully vaccinated, get one more Covid shot — once a year, that’s it,” Joe Biden said on Oct. 25, likening it to an annual flu shot. “If you get it you’re protected, and if you don’t, you’re putting yourself and other people at unnecessary risk.”

Related: European parliament member: Pfizer official admitted Covid vax was never tested to stop transmission of virus, October 11, 2022

In response to Biden’s comments, Robert F. Kennedy, Jr., founder, chairman of the board and chief legal counsel for Children’s Health Defense, said it is troubling that Biden “is so captive of a false and discredited narrative that he continues to aggressively promote a high-risk, zero-liability, experimental medical intervention with a product that doesn’t work as advertised and is causing horrendous health problems in Americans. It’s even more dismaying that he has used the prestige and moral authority of the presidency to recruit America’s corporations into a racketeering enterprise.”

A new study has found that the most recent Covid boosters are no better than the old ones.

“When given as a fourth dose, a bivalent mRNA vaccine targeting Omicron BA.4/BA.5 and an ancestral SARS-CoV-2 strain did not induce superior neutralizing antibody responses in humans, at the time period tested, compared to the original monovalent vaccine formulation,” the study says.

“The study should be very concerning to the CDC,” said Dr. Madhava Setty, senior science editor for The Defender. “Not only did the new bivalent formulation do no better than the old booster in eliciting an antibody response to the subvariants it was targeting, it resulted in a weaker response to related viruses. This suggests that the new booster could limit the recipient’s ability to respond to future variants.”

Setty said that “despite the CDC’s strong support of these boosters it would be safe to say at this point that they don’t provide the added protection against BA.4 and BA.5 as claimed. Having no results in humans to counter these findings, the CDC is now in an embarrassing position. They had no justification in authorizing these boosters without any human trials.”

Action . . . . Intelligence . . . . Publish